J Chem Inf Model - Profile-QSAR and Surrogate AutoShim protein-family modeling of proteases.

Tópicos

{ compound(1573) activ(1297) structur(1058) }
{ model(2656) set(1616) predict(1553) }
{ studi(1119) effect(1106) posit(819) }
{ analysi(2126) use(1163) compon(1037) }
{ group(2977) signific(1463) compar(1072) }
{ method(2212) result(1239) propos(1039) }
{ time(1939) patient(1703) rate(768) }
{ patient(1821) servic(1111) care(1106) }
{ drug(1928) target(777) effect(648) }
{ bind(1733) structur(1185) ligand(1036) }
{ method(1219) similar(1157) match(930) }
{ framework(1458) process(801) describ(734) }
{ problem(2511) optim(1539) algorithm(950) }
{ case(1353) use(1143) diagnosi(1136) }
{ perform(1367) use(1326) method(1137) }
{ age(1611) year(1155) adult(843) }
{ medic(1828) order(1363) alert(1069) }
{ cost(1906) reduc(1198) effect(832) }
{ use(976) code(926) identifi(902) }
{ imag(1057) registr(996) error(939) }
{ featur(3375) classif(2383) classifi(1994) }
{ patient(2315) diseas(1263) diabet(1191) }
{ studi(2440) review(1878) systemat(933) }
{ chang(1828) time(1643) increas(1301) }
{ method(1557) propos(1049) approach(1037) }
{ data(1714) softwar(1251) tool(1186) }
{ design(1359) user(1324) use(1319) }
{ method(984) reconstruct(947) comput(926) }
{ perform(999) metric(946) measur(919) }
{ research(1085) discuss(1038) issu(1018) }
{ import(1318) role(1303) understand(862) }
{ model(2341) predict(2261) use(1141) }
{ monitor(1329) mobil(1314) devic(1160) }
{ research(1218) medic(880) student(794) }
{ sampl(1606) size(1419) use(1276) }
{ data(3008) multipl(1320) sourc(1022) }
{ first(2504) two(1366) second(1323) }
{ intervent(3218) particip(2042) group(1664) }
{ use(2086) technolog(871) perceiv(783) }
{ health(1844) social(1437) communiti(874) }
{ result(1111) use(1088) new(759) }
{ model(3404) distribut(989) bayesian(671) }
{ can(774) often(719) complex(702) }
{ imag(1947) propos(1133) code(1026) }
{ data(1737) use(1416) pattern(1282) }
{ inform(2794) health(2639) internet(1427) }
{ system(1976) rule(880) can(841) }
{ measur(2081) correl(1212) valu(896) }
{ sequenc(1873) structur(1644) protein(1328) }
{ imag(2830) propos(1344) filter(1198) }
{ network(2748) neural(1063) input(814) }
{ imag(2675) segment(2577) method(1081) }
{ take(945) account(800) differ(722) }
{ motion(1329) object(1292) video(1091) }
{ assess(1506) score(1403) qualiti(1306) }
{ treatment(1704) effect(941) patient(846) }
{ surgeri(1148) surgic(1085) robot(1054) }
{ error(1145) method(1030) estim(1020) }
{ learn(2355) train(1041) set(1003) }
{ concept(1167) ontolog(924) domain(897) }
{ clinic(1479) use(1117) guidelin(835) }
{ algorithm(1844) comput(1787) effici(935) }
{ extract(1171) text(1153) clinic(932) }
{ control(1307) perform(991) simul(935) }
{ model(2220) cell(1177) simul(1124) }
{ care(1570) inform(1187) nurs(1089) }
{ general(901) number(790) one(736) }
{ search(2224) databas(1162) retriev(909) }
{ featur(1941) imag(1645) propos(1176) }
{ howev(809) still(633) remain(590) }
{ data(3963) clinic(1234) research(1004) }
{ studi(1410) differ(1259) use(1210) }
{ risk(3053) factor(974) diseas(938) }
{ system(1050) medic(1026) inform(1018) }
{ visual(1396) interact(850) tool(830) }
{ blood(1257) pressur(1144) flow(957) }
{ spatial(1525) area(1432) region(1030) }
{ record(1888) medic(1808) patient(1693) }
{ health(3367) inform(1360) care(1135) }
{ model(3480) simul(1196) paramet(876) }
{ ehr(2073) health(1662) electron(1139) }
{ state(1844) use(1261) util(961) }
{ patient(2837) hospit(1953) medic(668) }
{ data(2317) use(1299) case(1017) }
{ signal(2180) analysi(812) frequenc(800) }
{ gene(2352) biolog(1181) express(1162) }
{ activ(1138) subject(705) human(624) }
{ can(981) present(881) function(850) }
{ structur(1116) can(940) graph(676) }
{ high(1669) rate(1365) level(1280) }
{ cancer(2502) breast(956) screen(824) }
{ use(1733) differ(960) four(931) }
{ implement(1333) system(1263) develop(1122) }
{ survey(1388) particip(1329) question(1065) }
{ estim(2440) model(1874) function(577) }
{ decis(3086) make(1611) patient(1517) }
{ process(1125) use(805) approach(778) }
{ activ(1452) weight(1219) physic(1104) }
{ method(1969) cluster(1462) data(1082) }
{ detect(2391) sensit(1101) algorithm(908) }

Resumo

The 2D Profile-QSAR and 3D Surrogate AutoShim protein-family virtual screening methods were originally developed for kinases. They are the key components of an iterative medium-throughput screening alternative to expensive and time-consuming experimental high-throughput screening. Encouraged by the success with kinases, the S1-serine proteases were selected as a second protein family to tackle, based on the structural and SAR similarity among them, availability of structural and bioactivity data, and the current and future small-molecule drug discovery interest. A validation study on 24 S1-serine protease assay data sets from 16 unique proteases gave very promising results. Profile-QSAR gave a median R(ext)? = 0.60 for 24 assay data sets, and pairwise selectivity modeling on 60 protease pairs gave a median R(ext)? = 0.64, comparable to the performance for kinases. A 17-structure universal ensemble S1-serine protease surrogate receptor for Autoshim was developed from a collection of ~1500 X-ray structures. The predictive performance on 24 S1-serine protease assays was good, with a median R(ext)? = 0.41, but lower than had been obtained for kinases. Analysis suggested that the higher structural diversity of the protease structures, as well as smaller assay data sets and fewer potent compounds, both contributed to the decreased predictive power. In a prospective virtual screening application, 32 compounds were ordered from a 1.5 million archive and tested in a biochemical assay. Thirteen of the 32 compounds were active at IC50 = 10 ?M, a 41% hit-rate. Three new scaffolds were identified which are being followed up with testing of additional analogues. A SAR similarity analysis for this target against 13 other proteases also indicated two potential protease targets which were positively and negatively correlated with the activity of the target protease.

Resumo Limpo

d profileqsar d surrog autoshim proteinfamili virtual screen method origin develop kinas key compon iter mediumthroughput screen altern expens timeconsum experiment highthroughput screen encourag success kinas sserin proteas select second protein famili tackl base structur sar similar among avail structur bioactiv data current futur smallmolecul drug discoveri interest valid studi sserin proteas assay data set uniqu proteas gave promis result profileqsar gave median rext assay data set pairwis select model proteas pair gave median rext compar perform kinas structur univers ensembl sserin proteas surrog receptor autoshim develop collect xray structur predict perform sserin proteas assay good median rext lower obtain kinas analysi suggest higher structur divers proteas structur well smaller assay data set fewer potent compound contribut decreas predict power prospect virtual screen applic compound order million archiv test biochem assay thirteen compound activ ic m hitrat three new scaffold identifi follow test addit analogu sar similar analysi target proteas also indic two potenti proteas target posit negat correl activ target proteas

Resumos Similares

J Am Med Inform Assoc - Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds. ( 0,898479880107701 )
J Chem Inf Model - Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. ( 0,89111925087392 )
J Chem Inf Model - A new protocol for predicting novel GSK-3? ATP competitive inhibitors. ( 0,879168683201995 )
J Chem Inf Model - Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity. ( 0,870556602663654 )
J Chem Inf Model - Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening. ( 0,869149754420082 )
J Chem Inf Model - Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery. ( 0,865341079154906 )
J Chem Inf Model - Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods. ( 0,864058921542907 )
J Chem Inf Model - QSAR classification model for antibacterial compounds and its use in virtual screening. ( 0,851250993929789 )
J Chem Inf Model - Design and synthesis of new antioxidants predicted by the model developed on a set of pulvinic acid derivatives. ( 0,846755600202379 )
J Chem Inf Model - Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands. ( 0,833276769537757 )
J Chem Inf Model - Structure based model for the prediction of phospholipidosis induction potential of small molecules. ( 0,829840722943055 )
J Chem Inf Model - Construction and use of fragment-augmented molecular Hasse diagrams. ( 0,829779721358397 )
J Chem Inf Model - Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application. ( 0,827562971730627 )
J Chem Inf Model - Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase. ( 0,811071147251374 )
J Chem Inf Model - Compound set enrichment: a novel approach to analysis of primary HTS data. ( 0,810918922546022 )
J Chem Inf Model - Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modification. ( 0,809688802739875 )
J Chem Inf Model - Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. ( 0,806943157575053 )
J Chem Inf Model - A multivariate chemical similarity approach to search for drugs of potential environmental concern. ( 0,805182703524507 )
J Chem Inf Model - Combining horizontal and vertical substructure relationships in scaffold hierarchies for activity prediction. ( 0,803954921231972 )
J Chem Inf Model - Predicting myelosuppression of drugs from in silico models. ( 0,803455212620539 )
J Chem Inf Model - TIN-a combinatorial compound collection of synthetically feasible multicomponent synthesis products. ( 0,803141801563565 )
J Chem Inf Model - Freely available conformer generation methods: how good are they? ( 0,803095876596225 )
J Chem Inf Model - Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. ( 0,796750792011609 )
J Chem Inf Model - In silico prediction of total human plasma clearance. ( 0,795799608644125 )
J Chem Inf Model - Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities. ( 0,795599438874683 )
J Chem Inf Model - Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screening. ( 0,793125078872303 )
J Chem Inf Model - Modeling drug-induced anorexia by molecular topology. ( 0,792278253905042 )
J Chem Inf Model - Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. ( 0,789747854044517 )
J Chem Inf Model - Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs. ( 0,789510262232457 )
J Chem Inf Model - Increasing the coverage of medicinal chemistry-relevant space in commercial fragments screening. ( 0,787840715274485 )
J Chem Inf Model - Compound optimization through data set-dependent chemical transformations. ( 0,783470198499152 )
J Chem Inf Model - Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. ( 0,783146822441817 )
J Chem Inf Model - Visualization and virtual screening of the chemical universe database GDB-17. ( 0,782515504405623 )
J Chem Inf Model - Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening. ( 0,781211122667794 )
Curr Comput Aided Drug Des - Development of Chemical Compound Libraries for In Silico Drug Screening. ( 0,780849379040441 )
J Integr Bioinform - Database supported candidate search for metabolite identification. ( 0,780616582781702 )
J Chem Inf Model - ColBioS-FlavRC: a collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes. ( 0,777744090681797 )
J Chem Inf Model - Quantitative structure-activity relationship models of chemical transformations from matched pairs analyses. ( 0,775986341854304 )
J Chem Inf Model - Novel mycosin protease MycP1 inhibitors identified by virtual screening and 4D fingerprints. ( 0,775285861077478 )
J Chem Inf Model - Identification of novel liver X receptor activators by structure-based modeling. ( 0,774609221852429 )
J Chem Inf Model - Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces. ( 0,773736703975396 )
J Chem Inf Model - De novo design of drug-like molecules by a fragment-based molecular evolutionary approach. ( 0,772612476247534 )
J Chem Inf Model - Automated recycling of chemistry for virtual screening and library design. ( 0,772338381271979 )
J Chem Inf Model - Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. ( 0,771657767992376 )
J Chem Inf Model - Discovery of a7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13. ( 0,771125388447922 )
J Chem Inf Model - From activity cliffs to activity ridges: informative data structures for SAR analysis. ( 0,771094907397329 )
J Chem Inf Model - Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library. ( 0,771010730904448 )
J Chem Inf Model - Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulators. ( 0,769961490344992 )
J Chem Inf Model - Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening. ( 0,769043189673087 )
J Chem Inf Model - Rationalizing the role of SAR tolerance for ligand-based virtual screening. ( 0,768227910055298 )
J Chem Inf Model - In silico enzymatic synthesis of a 400,000 compound biochemical database for nontargeted metabolomics. ( 0,767863639648662 )
J Chem Inf Model - Automatic tailoring and transplanting: a practical method that makes virtual screening more useful. ( 0,767357494789546 )
J Chem Inf Model - Classification of compounds with distinct or overlapping multi-target activities and diverse molecular mechanisms using emerging chemical patterns. ( 0,766742784949331 )
J Chem Inf Model - Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data. ( 0,766492220025344 )
J Chem Inf Model - G-protein coupled receptors virtual screening using genetic algorithm focused chemical space. ( 0,765709725177425 )
J Chem Inf Model - Prediction of individual compounds forming activity cliffs using emerging chemical patterns. ( 0,76550984623998 )
J Chem Inf Model - Target-independent prediction of drug synergies using only drug lipophilicity. ( 0,764324285468315 )
J Chem Inf Model - Capturing structure-activity relationships from chemogenomic spaces. ( 0,764158936887918 )
J Chem Inf Model - BioSM: metabolomics tool for identifying endogenous mammalian biochemical structures in chemical structure space. ( 0,763880370744333 )
J Chem Inf Model - Identification of multitarget activity ridges in high-dimensional bioactivity spaces. ( 0,763389671609371 )
J Chem Inf Model - Structural similarity based kriging for quantitative structure activity and property relationship modeling. ( 0,76318367927838 )
J Chem Inf Model - QSAR modeling of imbalanced high-throughput screening data in PubChem. ( 0,763090889874717 )
J Chem Inf Model - Synthesis, bioassay, and molecular field topology analysis of diverse vasodilatory heterocycles. ( 0,762639269702741 )
J Chem Inf Model - Identification of novel serotonin transporter compounds by virtual screening. ( 0,761577780696277 )
J Chem Inf Model - Automated building of organometallic complexes from 3D fragments. ( 0,761324535345463 )
J Chem Inf Model - Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors. ( 0,75989635372643 )
J Chem Inf Model - Design of multitarget activity landscapes that capture hierarchical activity cliff distributions. ( 0,759722326563318 )
J Chem Inf Model - Jointly handling potency and toxicity of antimicrobial peptidomimetics by simple rules from desirability theory and chemoinformatics. ( 0,759717841483367 )
J Chem Inf Model - Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining. ( 0,759697151339035 )
J Chem Inf Model - Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening. ( 0,7589116485379 )
J Chem Inf Model - Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening. ( 0,758788004270361 )
J Chem Inf Model - Discovery of novel histamine H4 and serotonin transporter ligands using the topological feature tree descriptor. ( 0,758771212303515 )
J Chem Inf Model - How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. ( 0,758518918721338 )
J Chem Inf Model - Searching for recursively defined generic chemical patterns in nonenumerated fragment spaces. ( 0,756729955947978 )
J Chem Inf Model - Identification of novel S-adenosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation. ( 0,756390616119439 )
J Chem Inf Model - How accurately can we predict the melting points of drug-like compounds? ( 0,754067353375112 )
J Chem Inf Model - Natural product-like virtual libraries: recursive atom-based enumeration. ( 0,753828555890473 )
J Chem Inf Model - Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations. ( 0,753268074766327 )
J Chem Inf Model - Scanning structure-activity relationships with structure-activity similarity and related maps: from consensus activity cliffs to selectivity switches. ( 0,753066983471335 )
J Chem Inf Model - Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors. ( 0,752746951718349 )
J Chem Inf Model - In silico prediction of aqueous solubility using simple QSPR models: the importance of phenol and phenol-like moieties. ( 0,750417632099268 )
J Chem Inf Model - Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes. ( 0,749901925839534 )
J Chem Inf Model - Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation. ( 0,749756491387752 )
J Chem Inf Model - Fragment-based lead discovery and design. ( 0,748963048885413 )
J Chem Inf Model - Design of a three-dimensional multitarget activity landscape. ( 0,748763581025107 )
J Chem Inf Model - Coping with unbalanced class data sets in oral absorption models. ( 0,748097724360193 )
J Chem Inf Model - Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model. ( 0,747605776201171 )
J Chem Inf Model - Similarity boosted quantitative structure-activity relationship--a systematic study of enhancing structural descriptors by molecular similarity. ( 0,746891352888273 )
J Chem Inf Model - Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery. ( 0,74389914290843 )
J Chem Inf Model - Novel method for pharmacophore analysis by examining the joint pharmacophore space. ( 0,742997696623942 )
J Chem Inf Model - Scaffold diversity of exemplified medicinal chemistry space. ( 0,741926663814725 )
J Chem Inf Model - Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. ( 0,740768163939228 )
J Chem Inf Model - Best of both worlds: on the complementarity of ligand-based and structure-based virtual screening. ( 0,740626993432171 )
J Chem Inf Model - Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. ( 0,739920297382383 )
J Chem Inf Model - Introduction of target cliffs as a concept to identify and describe complex molecular selectivity patterns. ( 0,739815547298891 )
J Chem Inf Model - Development of Ecom50 and retention index models for nontargeted metabolomics: identification of 1,3-dicyclohexylurea in human serum by HPLC/mass spectrometry. ( 0,738948473028182 )
J Chem Inf Model - Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors. ( 0,738889057913868 )
J Chem Inf Model - Computational repositioning and experimental validation of approved drugs for HIF-prolyl hydroxylase inhibition. ( 0,738833336390676 )
J Chem Inf Model - Identification of novel potential antibiotics against Staphylococcus using structure-based drug screening targeting dihydrofolate reductase. ( 0,73883079964261 )
J Chem Inf Model - Oversampling to overcome overfitting: exploring the relationship between data set composition, molecular descriptors, and predictive modeling methods. ( 0,738429152042242 )